Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus

NCT00432276 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

803

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Alogliptin
DRUG: Pioglitazone
DRUG: Metformin
DRUG: Placebo

Sponsor

Takeda